Caveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of Prometheus

Lisa Bodei; Ken Herrmann; Richard P. Baum; Mark Kidd; Anna Malczewska; Irvin M. Modlin

doi:10.2967/jnumed.118.219386

EditorialEditorial

Caveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of Prometheus

Lisa Bodei, Ken Herrmann, Richard P. Baum, Mark Kidd, Anna Malczewska and Irvin M. Modlin

Journal of Nuclear Medicine January 2019, 60 (1) 7-8; DOI: https://doi.org/10.2967/jnumed.118.219386

Lisa Bodei

1Memorial Sloan Kettering Cancer Center, New York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ken Herrmann

2Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California

3Klinik für Nuklearmedizin, Universitätsklinikum Essen, Essen, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Richard P. Baum

4Theranostics Center for Molecular Radiotherapy and Imaging, Zentralklinik Bad Berka, Bad Berka, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark Kidd

5Wren Laboratories, Branford, Connecticut

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anna Malczewska

6Department of Endocrinology and Neuroendocrine Tumors, Medical University of Silesia, Katowice, Poland; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Irvin M. Modlin

7Yale School of Medicine, Department of Surgery, New Haven, Connecticut

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

Article Information

vol. 60 no. 1 7-8

DOI

https://doi.org/10.2967/jnumed.118.219386

PubMed

30602595

Published By

Society of Nuclear Medicine

Print ISSN

0161-5505

Online ISSN

2159-662X

History

Received for publication October 16, 2018
Accepted for publication November 14, 2018
Published online January 2, 2019.

Author Information

Statistics from Altmetric.com

Cited By...

7 Citations
9 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest

Lisa Bodei, Mark S. Kidd, Aviral Singh, Wouter A. van der Zwan, Stefano Severi, Ignat A. Drozdov, Anna Malczewska, Richard P. Baum, Dik J. Kwekkeboom, Giovanni Paganelli, Eric P. Krenning, Irvin M. Modlin

European Journal of Nuclear Medicine and Molecular Imaging 2020 47 4
First-in-Humans Study of the SSTR Antagonist 177Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms: Dosimetry, Safety, and Efficacy

Richard P. Baum, Jingjing Zhang, Christiane Schuchardt, Dirk Müller, Helmut Mäcke

Journal of Nuclear Medicine 2021 62 11
Image quality and lesion detectability in low-dose pediatric 18F-FDG scans using total-body PET/CT

Yu-Mo Zhao, Ying-He Li, Tao Chen, Wei-Guang Zhang, Lin-Hao Wang, Jiatai Feng, Chenwei Li, Xu Zhang, Wei Fan, Ying-Ying Hu

European Journal of Nuclear Medicine and Molecular Imaging 2021 48 11
Prognostic Value of 18F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy

Jingjing Zhang, Qingxing Liu, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni, Richard P. Baum

Journal of Nuclear Medicine 2020 61 11
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT

Rudolf A. Werner, Thorsten Derlin, Steven P. Rowe, Lena Bundschuh, Gabriel T. Sheikh, Martin G. Pomper, Sebastian Schulz, Takahiro Higuchi, Andreas K. Buck, Frank M. Bengel, Ralph A. Bundschuh, Constantin Lapa

Journal of Nuclear Medicine 2021 62 4
Radiation use in diagnostic imaging in children: approaching the value of the pediatric radiology community

Donald P. Frush, Erich Sorantin

Pediatric Radiology 2021 51 4
Meckel diverticulum scintigraphy: technique, findings and diagnostic pitfalls

Hassan A. Aboughalia, Safia H. E. Cheeney, Saeed Elojeimy, Lisa C. Blacklock, Marguerite T. Parisi

Pediatric Radiology 2022 53 3
Congenital hyperinsulinism: localization of a focal lesion with 18F-FDOPA positron emission tomography

Lisa J. States, Susan A. Becker, Diva D. De León

Pediatric Radiology 2022 52 4
The concept of the ‘carcinoid’: The phylogenic and ontogenic evolution of the unresolved karzinoide conundrum

Irvin M. Modlin, Mark Kidd

Current Opinion in Endocrine and Metabolic Research 2021 18

Article usage

Article usage: January 2019 to April 2025

	Full	Pdf
Jan 2019	721	215
Feb 2019	535	31
Mar 2019	319	41
Apr 2019	131	21
May 2019	103	15
Jun 2019	140	9
Jul 2019	99	21
Aug 2019	107	14
Sep 2019	102	17
Oct 2019	116	12
Nov 2019	64	19
Dec 2019	36	8
Jan 2020	40	12
Feb 2020	46	10
Mar 2020	30	8
Apr 2020	35	5
May 2020	23	5
Jun 2020	21	5
Jul 2020	17	10
Aug 2020	22	7
Sep 2020	21	2
Oct 2020	22	9
Nov 2020	8	3
Dec 2020	15	8
Jan 2021	14	2
Feb 2021	12	10
Mar 2021	6	10
Apr 2021	14	5
May 2021	14	4
Jun 2021	19	2
Jul 2021	9	14
Aug 2021	16	15
Sep 2021	10	6
Oct 2021	16	21
Nov 2021	26	18
Dec 2021	21	16
Jan 2022	9	8
Feb 2022	16	6
Mar 2022	21	5
Apr 2022	16	5
May 2022	17	8
Jun 2022	7	4
Jul 2022	13	4
Aug 2022	12	7
Sep 2022	16	12
Oct 2022	10	5
Nov 2022	16	8
Dec 2022	15	2
Jan 2023	44	9
Feb 2023	18	5
Mar 2023	17	4
Apr 2023	18	7
May 2023	10	7
Jun 2023	16	6
Jul 2023	13	7
Aug 2023	9	6
Sep 2023	7	3
Oct 2023	8	2
Nov 2023	10	4
Dec 2023	30	2
Jan 2024	15	6
Feb 2024	3	4
Mar 2024	15	33
Apr 2024	40	13
May 2024	22	6
Jun 2024	19	5
Jul 2024	17	11
Aug 2024	28	9
Sep 2024	31	6
Oct 2024	26	7
Nov 2024	18	9
Dec 2024	16	1
Jan 2025	5	6
Feb 2025	37	10
Mar 2025	39	21
Apr 2025	27	13

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 60, Issue 1

January 1, 2019

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Caveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of Prometheus

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Caveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of Prometheus

Lisa Bodei, Ken Herrmann, Richard P. Baum, Mark Kidd, Anna Malczewska, Irvin M. Modlin

Journal of Nuclear Medicine Jan 2019, 60 (1) 7-8; DOI: 10.2967/jnumed.118.219386

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Caveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of Prometheus

Lisa Bodei, Ken Herrmann, Richard P. Baum, Mark Kidd, Anna Malczewska, Irvin M. Modlin

Journal of Nuclear Medicine Jan 2019, 60 (1) 7-8; DOI: 10.2967/jnumed.118.219386

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
- DISCLOSURE
- REFERENCES
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

First-in-Humans Study of the SSTR Antagonist 177Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms: Dosimetry, Safety, and Efficacy
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT
Prognostic Value of 18F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy

Google Scholar

Main menu

User menu

Search

Caveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of Prometheus

Article Information

Author Information

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: January 2019 to April 2025

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles